Evidence map›Paper›PMID 34254539›Full record

ArticleDrug delivery2021

Anti-inflammatory and antioxidant effects of nanoformulations composed of metal-organic frameworks delivering rutin and/or piperine natural agents.

Khaled AbouAitah, Imane M Higazy, Anna Swiderska-Sroda, Reda M Abdelhameed, Stanislaw Gierlotka, Tarik A Mohamed, Urszula Szałaj, Witold Lojkowski

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Khaled AbouAitahLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0001-8413-6738
Imane M HigazyDepartment of Pharmaceutical Technology, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), Giza, Egypt.ORCID https://orcid.org/0000-0002-4200-0418
Anna Swiderska-SrodaLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0001-6993-1741
Reda M AbdelhameedApplied Organic Chemistry Department, Chemical Industries Research Division, National Research Centre (NRC), Giza, Egypt.ORCID https://orcid.org/0000-0003-1700-5361
Stanislaw GierlotkaLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0001-9280-7407
Tarik A MohamedChemistry of Medicinal Plants Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), Giza, Egypt.ORCID https://orcid.org/0000-0003-1639-3518
Urszula SzałajLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0003-2304-1481
Witold LojkowskiLaboratory of Nanostructures and Nanomedicine, Institute of High Pressure Physics, Polish Academy of Sciences, Warsaw, Poland.ORCID https://orcid.org/0000-0001-8521-0688
Institute of High Pressure Physics · PLNational Research Centre · EGWarsaw University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant-derived natural medicines have been extensively studied for anti-inflammatory or antioxidant properties, but challenges to their clinical use include low bioavailability, poor solubility in water, and difficult-to-control release kinetics. Nanomedicine may offer innovative solutions that can enhance the therapeutic activity and control release kinetics of these agents, opening the way to translating them into the clinic. Two agents of particular interest are rutin (Ru), a flavonoid, and piperine (Pip), an alkaloid, which exhibit a range of pharmacological activities that include antioxidant and anti-inflammatory effects. In this work, nanoformulations were developed consisting of two metal-organic frameworks (MOFs) with surface modifications, Ti-MOF and Zr-MOF, each of them loaded with Ru and/or Pip. Both MOFs and nanoformulations were characterized and evaluated

Indexed as

AlkaloidsAnimalsAnti-Inflammatory AgentsAntioxidantsBenzodioxolesChemistry, PharmaceuticalDelayed-Action PreparationsDrug CarriersDrug CombinationsDrug LiberationHydrogen-Ion ConcentrationMaleMetal-Organic FrameworksNanoparticlesPiperidinesPolyunsaturated AlkamidesAlkaloidsAnti-Inflammatory AgentsAntioxidantsBenzodioxolesDelayed-Action PreparationsDrug CarriersDrug CombinationsMetal-Organic FrameworksPiperidinespiperinePolyunsaturated AlkamidesRutinDelivery systemin vivo antioxidant and anti-inflammatorymetal organic framework (MOF)release kineticsrutin flavonoid and piperine alkaloid natural agents nanoformulations

Identifiers

PMID34254539
PMCPMC8280904
OpenAlexW3179749562

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.